TR
Tilak Ram
About Tilak Ram
Data last updated:
Tilak Ram is a Director at Novatro Laboratories Private Limited (since 2022) and Director at Wirmon Laboratories Private Limited (since 2022). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Novatro Laboratories Private Limited at ₹9.35 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novatro Laboratories Private Limited U24230DL2022PTC399347 | Director | 31 May 2022 | 2022 | ₹9.35 Cr (FY 2023) | Active |
| Wirmon Laboratories Private Limited U24110DL2021PTC382193 | Director | 02 Aug 2022 | 2021 | Active |
Board colleagues of Tilak Ram
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sharat Chandra Jha | 09201243 | Novatro Laboratories Private Limited , Wirmon Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tilak Ram
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tilak Ram
Tilak Ram currently holds 2 directorships: Novatro Laboratories Private Limited (Director, since 31 May 2022, revenue ₹9.35 Cr (FY 2023)); Wirmon Laboratories Private Limited (Director, since 02 Aug 2022).
Tilak Ram was first appointed on 31 May 2022 as Director at Novatro Laboratories Private Limited.
The current boards of Tilak Ram's companies include Sharat Chandra Jha (Novatro Laboratories Private Limited).